| SATURDAY, FEBRUARY 8
, 2003 |
| HALL A |
| 08:30 – 10:30 |
GnRH Analogues in the Management of Endometriosis – Pitfalls
of the past-current place perspectives for the future
Chairmen:
K.W. Schweppe, Germany
N. Terakawa, Japan
|
| |
PATHOGENESIS
OF ENDOMETRIOSIS
J.C.H. Evers, The Netherlands |
| |
GNRH-ANALOGUES
FOR THE TREATMENT OF ENDOMETRIOSIS ASSOCIATED INFERTILITY
K. Buehler, Germany |
| |
ENDOMETRIOSIS
ASSOCIATED INFERTILITY AND IVF-ET
J. Kleinstein, Germany |
| |
ENDOMETRIOSIS
AND HUMAN EMBRYO IMPLANTATION
J.A. Garcia-Velasco, Spain |
| |
GNRH-ANTAGONISTS
NEW PATHWAYS IN THE TREATMENT OF ENDOMETRIOSIS
R.E. Felberbaum, W. Kuepker, K. Diedrich, Germany |
| 11:00 – 13:00 |
GnRH Analogues in the Management of Endometriosis – Pitfalls
of the past-current place perspectives for the future (continued)
Chairmen:
B. Lunenfeld, Israel
K. Buehler, Germany
|
| |
GNRH-ANTAGONIST:
A TREATMENT OPTION IN ADENOMYOSIS?
W. Kuepker, Germany |
| |
LONG-TERM
CONTINUOS, INTERMITTENT AND RECURRENT TREATMENT OF ENDOMETRIOSIS
K.W. Schweppe, Germany |
| |
HORMONAL
SUPPRESSIVE THERAPY OF ENDOMETRIOSIS - ARE WE REALLY IMPROVING
PATIENT’S HEALTH?
Z. Blumenfeld, Israel |
| |
SPERM’S
- A NEW TREATMENT OPTION IN CHRONIC PAIN CAUSED BY ENDOMETRIOSIS?
K. Chwalisz, USA |
| 13:00 - 14:30 |
Lunch Break & Exhibition |
13:00 - 14:30
Working Lunch |
MANAGEMENT OF ENDOMETRIOSIS
Moderator:
J.L.H. Evers, The Netherlands |
13:00 - 14:30
Working Lunch |
MANAGEMENT OF FEMALE INFERTILITY
|
| 14:30 – 16:00 |
Knowledge Driven Drug Development - Sponsored by N.V.
Organon
Chairmen:
B.C.J.M. Fauser, The Netherlands
K. Gordon, USA
|
| |
ORAL
LH AGONIST: COMPUTER AIDED MOLECULAR DESIGN
R. Hanssen, The Netherlands |
| |
LONG
ACTING FSH: PREDICTION OF CLINICAL OUTCOME
G. Borm, The Netherlands |
| |
OPTIMIZATION
OF GnRH ANTAGONIST PROTOCOLS: CLINICAL EXPERIENCE WITH GANIRELIX
D. Shapiro, USA |
| 16:30 – 18:00 |
GnRH-Analogues in Breast and Gynecological Cancers
Sponsored by AstraZeneca - Germany
Chairmen:
W. Jonat, Germany
J.G.M. Klijn, The Netherlands
|
| |
ROLE
OF LHRH AGONISTS IN PREMENOPAUSAL WOMEN WITH OESTROGEN RECEPTOR-POSITIVE
(ER+) BREAST CANCER
W. Jonat, Germany |
| |
ADJUVANT
ENDOCRINE THERAPY FOR PREMENOPAUSAL WOMEN WITH BREAST CANCER
R. Jakesz, Austria |
| |
LHRH-AGONIST
THERAPY IN BREAST CANCER
J.G.M. Klijn, The Netherlands |
| |
GNRH
ANALOGUES IN ENDOMETRIAL AND OVARIAN CANCER
G. Emons, Germany |
| |
GNRH-
AGONIST LEUPRORELIN REDUCES CELL PROLIFERATION AND DOES NOT
INDUCE OR INHIBIT CELL DIFFERENTIATION OF UTERINE LEIOMYOMATA
K.J. Wagner, P.A. Regidor, R. Yildiz, M Regidor, E. Winterhager,
A.E. Schindler, Germany
|
| 18:00 – 19:00 |
Assisted Reproduction Controversies II
Chairmen:
S. Daya, Canada
S. Mashiach, Israel |
| |
DO
GNRHA EFFECT ON THE LUTEAL PHASE OF ASSISTED REPRODUCTION CYCLES
INTERFERE WITH PREGNANCY OUTCOME?
S. Geber, A.C. Moreira, M. Fernanda Rezende, M. Sampaio,
Brazil |
| |
PROGRAMMING
OOCYTE RETRIEVAL FOR 1-DAY PER WEEK IN IVF CYCLES USING GnRHa
M. Valle, M. Sampaio, M. Lemgruber, S. Geber, Brazil |
| |
GONADOTROPIN
SECRETION IN WOMEN WITH HYPOTHALAMIC AMENORRHEA IS INHIBITED
BY TEVERELIX, AN LHRH ANTAGONIST, THAT, HOWEVER, DOES NOT ELICITE
ANY LATE REBOUND INCREASE
S. Destefanis, Italy |
| |
OBSTETRIC
OUTCOMES OF PREGNANCIES AFTER INADVERTENT EXPOSURE TO DAILY
GONADOTROPHIN - RELEASING HORMONE ANALOGUE - SINGAPORE EXPERIENCE
C.T. Yeong, Singapore
|
| HALL B |
| 08:30 – 10:30 |
GnRH – Its Role in Prostate Cancer |
Chairmen:
F. Labrie, Canada
S.V. Tavtigian, Canada
|
| |
ABARELIX,
A GNRH ANTAGONIST, FOR THE INITIAL TREATMENT OF ADVANCED SYMPTOMATIC
PROSTATE CANCER PATIENTS COMPLETELY AVOIDS THE REQUIREMENT FOR
SURGICAL CASTRATION
M.B. Garnick, USA |
| |
RADIOTHERAPY
IN COMBINATION WITH NEOADJUVANT AND/OR ADJUVANT HORMONAL TREATMENT
IN PATIENTS WITH LOCALY ADVANCED PROSTATE CANCER
T. Wiegel, Germany |
| |
HOW
GNRH AGONISTS HAVE MADE POSSIBLE THE CLINICAL TRIALS SHOWING
THE MARKED BENEFITS OF ANDROGEN BLOCKADE ON SURVIVAL IN LOCALIZED
PROSTATE CANCER
F. Labrie, Canada |
| |
PROSTATE
CANCER SUSCEPTIBILITY GENES
S.V. Tavtigian, J. Simard, M. Dumont, F. Labrie, France,
Canada |
| 11:00 - 13:00 |
GnRH - It’s Role in Prostate Cancer II
Chairmen:
D. Jocham, Germany
C. Doehn, Germany
|
| |
TESTOSTERONE
SUBSTITUTION AND PROSTATE CANCER
G. Ludwig, Germany |
| |
INTERMITTENT
ANDROGEN BLOCKADE: CURRENT VIEW
J. Breul, Germany |
 |
FLARE-UP:
MECHANISM AND CLINICAL RELEVANCE
C. Doehn, Germany
|
| |
EFFECT
OF HORMONAL TREATMENT ON ADHESION MOLECULE EXPRESSION IN HUMAN
PROSTATIC CANCER CELLS
F. Iacopino, C. Angelucci, S. Capucci, G. Sica, Italy |
| |
EFFECT
OF HORMONES AND GROWTH FACTORS ON GnRH RECEPTOR EXPRESSION IN
HUMAN PROSTATE CANCER CELL LINES
G. Lama, G. Sica, Italy |
16:30 – 18:00
|
Basic Science and Pharmacology
Chairmen:
J. Engel, Germany
T. Maruo, Japan
|
| |
DYNAMIC
EVALUATION OF PITUITARY DESENSITAZION DURING EIGHT WEEKS AFTER
A SINGLE DOSE OF TRIPTORELIN AND LEUPRORELIN ACETATE
D. Carone, Italy |
| |
DEVELOPMENT
OF GS-121 AND GS-123, NOVEL SUSTAINED RELEASE LEUPROLIDE DEPOT
PRODUCTS
T.L. Scott, J. Rashba-Step, R. Proos, T. Marshell, D.
Davidson Easson Jr., USA |
| |
LONG-TERM
EFFECTS AND REVERSIBILITY OF PUBERTAL SUPRESSION BY GnRH AGONIST
AND GnRH ANTAGONIST IN A NON-HUMAN PRIMATE MODEL
C-J. Partsch, Germany |
| |
THE
ROLE OF GNRH-AGONISTS IN PREVENTION OF POSTOPERATIVE ADHESIONS
A.E. Schindler, Germany |
| |
CHEMOPREVENTION
FOR YOUNG WOMEN AT HIGH RISK FOR BREAST CANCER USING A GONADOTROPIN
RELEASING HORMONE AGONIST (GNRHA) AND LOW-DOSE ADD-BACK SEX
STEROIDS CONTRACEPTIVE REGIMEN
A.M. Daniels, M.C. Pike, D.V. Spicer, J.R. Daniels, G.
Ursin, J.N. Weitzel, USA |
| |
TREATMENT
WITH THE GNRH AGONIST (GNRHA) DESLORELIN (D) AND LOW-DOSE ADD-BACK
ESTRADIOL (E2) IS EFFECTIVE IN SIGNIFICANTLY REDUCING PAIN,
BLEEDING, AND UTERINE VOLUME (UV) WHILE MAINTAINING BONE MINERAL
DENSITY (BMD) IN WOMEN WITH SYMPTOMATIC UTERINE FIBROIDS (UF)
A.M. Daniels, M.C. Pike, J.R. Daniels, D.V. Spicer, USA |
| |
DETERMINATION
OF THE TRANSCRIPT PROFILE OF HUMAN ENDOMETRIUM
J.M. Borthwick, D.S. Charnock-Jones, B.D. Tom, M.L. Hull, R.
Teirney, S.C. Phillips, S.K. Smith, UK
|
